PRISM MediaWire

Medical Devices

SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference

SMRSC 2024 brings global medical experts and technological innovators together to explore the future of robotic surgery

22 January 2024

Oncocyte to Present at the Sequire Investor Summit in Puerto Rico

IRVINE, CA, January 16, 2024 - PRISM MediaWire - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today announced that CEO Josh Riggs will be presenting a corporate overview at the upcoming Sequire Investor Summit 2024. The conference is scheduled for...

16 January 2024

PRISM MarketView Announces the Addition of Verastem to Emerging Women’s Health Index

NEW YORK, NY, January 12, 2024 - PRISM MediaWire -In concert with Cervical Health Awareness Month, PRISM MarketView has added Verastem, Inc., a biopharmaceutical company focused on the development and commercialization of new medicines for patients combating various type...

12 January 2024

BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role

Mr. McCarrey brings a strong track record of success and deep experience in regenerative medicine markets

11 January 2024

SS Innovations Achieves Significant Milestones in 2023

Company’s award winning SSi Mantra surgical robotic system has completed over 550 surgeries and is clinically validated to perform more than 40 different types of surgical procedures

8 January 2024

PRISM MarketView Launches Emerging Women’s Health Index

Global women’s health market projected to reach $67.07 billion by 2031

4 January 2024

SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa

Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System in Healthcare Facilities across the African Continent

25 December 2023

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

Lipella Granted Two Orphan Drug Designations by FDA

20 December 2023

BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors

POMPANO BEACH, FLORIDA, December 19, 2023 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today annou...

19 December 2023

CMS Establishes National Pricing for BioStem Technologies Product AmnioWrap2™

“This change means that AmnioWrap2™ (AW2) can now be offered to all Medicare providers throughout the country. BioStem Technologies is taking the lead in wound care innovation, leveraging our distinctive BioRetain® process. This is more than a breakthrough; it's a transf...

14 December 2023